• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.

作者信息

Saliba Rima M, Veltri Lauren, Rondon Gabriela, Chen Julianne, Al-Atrash Gheath, Alousi Amin, Martinez Charles, Augustine LaJerald, Hosing Chitra M, Oran Betul, Rezvani Katayoun, Shpall Elisabeth J, Kebriaei Partow, Khouri Issa F, Popat Uday, Champlin Richard E, Ciurea Stefan O

机构信息

The University of Texas MD Anderson Cancer Center, Rochester, NY.

University of West Virginia.

出版信息

Haematologica. 2021 Jan 1;106(1):269-274. doi: 10.3324/haematol.2019.227371.

DOI:10.3324/haematol.2019.227371
PMID:32107328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7776345/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92b/7776345/19c0ba98ed28/106269.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92b/7776345/19c0ba98ed28/106269.fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a92b/7776345/19c0ba98ed28/106269.fig1.jpg

相似文献

1
Impact of graft composition on outcomes of haploidentical bone marrow stem cell transplantation.移植物组成对单倍体相合骨髓干细胞移植结局的影响。
Haematologica. 2021 Jan 1;106(1):269-274. doi: 10.3324/haematol.2019.227371.
2
Bone marrow versus peripheral blood as a graft source for haploidentical donor transplantation in adults using post-transplant cyclophosphamide-A systematic review and meta-analysis.异基因造血干细胞移植中，使用环磷酰胺预处理的单倍体相合供者，骨髓来源与外周血来源对移植结果的影响：系统评价与荟萃分析。
Crit Rev Oncol Hematol. 2019 Jan;133:120-128. doi: 10.1016/j.critrevonc.2018.05.017. Epub 2018 Jun 11.
3
Successful haploidentical bone marrow transplantation in Griscelli syndrome type 2 with non-busulfan-based regimen and post-transplantation cyclophosphamide: a case report and review of the literature.采用非白消安方案及移植后环磷酰胺成功进行单倍型相合骨髓移植治疗2型格里塞利综合征：1例报告并文献复习
Pediatr Hematol Oncol. 2024 May;41(4):296-300. doi: 10.1080/08880018.2023.2273880. Epub 2023 Oct 31.
4
Haploidentical bone marrow transplantation in a child with fatal hepatic failure due to graft-versus-host disease after cord blood transplantation.脐血移植后因移植物抗宿主病导致致命性肝衰竭患儿的单倍体相合骨髓移植
Leuk Lymphoma. 2020 May;61(5):1263-1264. doi: 10.1080/10428194.2019.1706730. Epub 2019 Dec 26.
5
Haploidentical stem cell transplantation-bone marrow vs peripheral blood.单倍体相合干细胞移植——骨髓与外周血
Transfus Apher Sci. 2018 Apr;57(2):168-170. doi: 10.1016/j.transci.2018.04.015. Epub 2018 Apr 19.
6
[Haploidentical hematopoietic stem cell transplantation: Guidelines from the Francophone society of marrow transplantation and cellular therapy (SFGM-TC)].[单倍型相合造血干细胞移植：法语国家骨髓移植与细胞治疗协会（SFGM-TC）指南]
Bull Cancer. 2016 Nov;103(11S):S229-S242. doi: 10.1016/j.bulcan.2016.09.007. Epub 2016 Nov 11.
7
Reduced toxicity, myeloablative HLA-haploidentical hematopoietic stem cell transplantation with post-transplantation cyclophosphamide for sickle cell disease.降低毒性的清髓性人类白细胞抗原半相合造血干细胞移植联合移植后环磷酰胺治疗镰状细胞病
Ann Hematol. 2017 Aug;96(8):1373-1377. doi: 10.1007/s00277-017-3030-x. Epub 2017 Jun 1.
8
Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide.接受移植后环磷酰胺治疗的HLA匹配和HLA单倍型相同移植后的可比复合终点。
Haematologica. 2017 Feb;102(2):391-400. doi: 10.3324/haematol.2016.144139. Epub 2016 Oct 20.
9
Haploidentical bone marrow transplantation with post transplant cyclophosphamide for patients with X-linked adrenoleukodystrophy: a suitable choice in an urgent situation.采用移植后环磷酰胺的单倍体相合骨髓移植治疗X连锁肾上腺脑白质营养不良患者：紧急情况下的合适选择。
Bone Marrow Transplant. 2018 Apr;53(4):392-399. doi: 10.1038/s41409-017-0015-2. Epub 2018 Jan 12.
10
[Successful treatment of secondary graft failure in a mixed-phenotype acute leukemia patient with haploidentical hematopoietic stem cell transplantation and post-transplant cyclophosphamide administration].[单倍体相合造血干细胞移植联合移植后环磷酰胺治疗混合表型急性白血病患者继发性移植失败成功]
Rinsho Ketsueki. 2018;59(5):485-488. doi: 10.11406/rinketsu.59.485.

引用本文的文献

1
The rewired immune microenvironment in leukemia.白血病中重新布线的免疫微环境。
Nat Immunol. 2025 Mar;26(3):351-365. doi: 10.1038/s41590-025-02096-9. Epub 2025 Feb 28.
2
Graft CD8 T-cell-based risk system predicts survival in antithymocyte globulin-based myeloablative haploidentical peripheral blood stem cell transplantation.基于移植物CD8 T细胞的风险系统可预测抗胸腺细胞球蛋白预处理的清髓性单倍体相合外周血干细胞移植的生存率。
Clin Transl Immunology. 2024 Jan 12;13(1):e1484. doi: 10.1002/cti2.1484. eCollection 2024.
3
High levels of NK Cells in graft are associated with reduced febrile neutropenia after haploidentical peripheral blood stem cell transplantation.
移植物中高水平的自然杀伤细胞与亲缘单倍体外周血造血干细胞移植后发热性中性粒细胞减少症的减少有关。
J Int Med Res. 2023 Jul;51(7):3000605231187932. doi: 10.1177/03000605231187932.
4
Selective depletion of naïve T cells by targeting CD45RA.通过靶向CD45RA选择性清除初始T细胞。
Front Oncol. 2023 Jan 27;12:1009143. doi: 10.3389/fonc.2022.1009143. eCollection 2022.
5
Haploidentical vs matched unrelated donors for patients with ALL: donor age matters more than donor type.对于 ALL 患者，与匹配的无关供体相比，单倍体相合供体：供体年龄比供体类型更重要。
Blood Adv. 2023 Apr 25;7(8):1594-1603. doi: 10.1182/bloodadvances.2022009240.
6
Ex vivo expansion of natural killer cells for hematological cancer immunotherapy: a systematic review and meta-analysis.自然杀伤细胞的体外扩增在血液系统恶性肿瘤免疫治疗中的应用：系统评价和荟萃分析。
Clin Exp Med. 2023 Oct;23(6):2503-2533. doi: 10.1007/s10238-022-00923-z. Epub 2022 Nov 4.
7
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.移植后环磷酰胺与常规移植物抗宿主病预防后移植物抗宿主病（GVHD）的特征。
Transplant Cell Ther. 2022 Oct;28(10):681-693. doi: 10.1016/j.jtct.2022.07.013. Epub 2022 Jul 16.